Citadel Advisors - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 113 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,768,185
+1.0%
414,399
+26.9%
0.00%
Q2 2023$2,740,577
-39.9%
326,648
-28.8%
0.00%
Q1 2023$4,556,311
-25.5%
458,843
-47.8%
0.00%
-100.0%
Q4 2022$6,117,513
-34.4%
878,953
-49.7%
0.00%
-50.0%
Q3 2022$9,330,000
-0.2%
1,747,328
-25.4%
0.00%0.0%
Q2 2022$9,346,000
-17.1%
2,342,278
-7.7%
0.00%0.0%
Q1 2022$11,275,000
+502.0%
2,536,636
+441.6%
0.00%
Q4 2021$1,873,000
+53.3%
468,317
+236.4%
0.00%
Q3 2021$1,222,000
-63.7%
139,233
-53.1%
0.00%
-100.0%
Q2 2021$3,362,000
-45.1%
296,777
-42.4%
0.00%
-50.0%
Q1 2021$6,123,000
-34.5%
515,392
-62.2%
0.00%0.0%
Q4 2020$9,355,000
+20.0%
1,363,687
+29.6%
0.00%0.0%
Q3 2020$7,796,000
+1973.4%
1,052,219
+1070.3%
0.00%
Q2 2020$376,000
+295.8%
89,907
+135.3%
0.00%
Q1 2020$95,000
-44.4%
38,206
+30.1%
0.00%
Q4 2019$171,000
+87.9%
29,363
+70.6%
0.00%
Q3 2019$91,000
-69.9%
17,215
-65.8%
0.00%
Q2 2019$302,000
-78.1%
50,405
-66.9%
0.00%
Q1 2019$1,377,000
+1186.9%
152,508
+1077.8%
0.00%
Q4 2018$107,000
+17.6%
12,948
+13.5%
0.00%
Q2 2018$91,000
+8.3%
11,409
+1.4%
0.00%
Q1 2018$84,00011,2500.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders